HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clarins

This article was originally published in The Rose Sheet

Executive Summary

Skin care sales up 14.5% to $361.3 mil. in 1999, the company announces Feb. 7. The business was driven by recovery in Asia as well as growth in the U.S., where the Clarins brand has moved to the fourth position in the selective market, Clarins says. Cosmetics sales increase 12.2% to $74.6 mil. boosted by new color collections Dreams and Light and Shades of the Future. Fragrance sales rise 8.1%, with Thierry Mugler Parfums and Azzaro fragrance sales up 24.2% and 5.6%, respectively. Net sales climb 11.9% to $675.2 mil. for the year

Skin care sales up 14.5% to $361.3 mil. in 1999, the company announces Feb. 7. The business was driven by recovery in Asia as well as growth in the U.S., where the Clarins brand has moved to the fourth position in the selective market, Clarins says. Cosmetics sales increase 12.2% to $74.6 mil. boosted by new color collections Dreams and Light and Shades of the Future. Fragrance sales rise 8.1%, with Thierry Mugler Parfums and Azzaro fragrance sales up 24.2% and 5.6%, respectively. Net sales climb 11.9% to $675.2 mil. for the year.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel